hydralazine hydrochloride 25 MG Oral Tablet

INDICATIONS AND USAGE Essential hypertension, alone or as an adjunct.

Mylan Institutional Inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] seizure` `[3] off label use` `[4] fatigue` `[5] maternal exposure during pregnancy` `[6] condition aggravated` `[7] epilepsy` `[8] foetal exposure during pregnancy` `[9] drug interaction` `[10] pyrexia`

2 years ago

ROUND ORANGE PLIVA 327

HOW SUPPLIED:

HYDRALAZINE HYDROCHLORIDE Tablets USP are available as: 10 mg orange, round, convex, unscored tablets, debossed with “PLIVA 398” on one side and plain on the other side. They are available as follows: NDC 51079-074-20 – Unit dose blister packages of 100 (10 cards of 10 tablets each). 25 mg orange, round, convex, unscored tablets, debossed with “PLIVA 327” on one side and plain on the other side. They are available as follows: NDC 51079-075-20 – Unit dose blister packages of 100 (10 cards of 10 tablets each). 50 mg orange, round, convex, unscored tablets, debossed with “PLIVA 328” on one side and plain on the other side. They are available as follows: NDC 51079-076-20 – Unit dose blister packages of 100 (10 cards of 10 tablets each). Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from light. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured in Czech Republic by: TEVA CZECH INDUSTRIES s.r.o. Opava-Komarov, Czech Republic Manufactured for: TEVA PHARMACEUTICALS USA, Inc. North Wales, PA 19454 Distributed by: Mylan Institutional Inc. Rockford, IL 61103 U.S.A. S-11344 R3 4/20

More pills like ROUND PLIVA 327

Related Pills

hydralazine hydrochloride 50 MG Oral Tablet

Mylan Institutional Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site